Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness
スポンサーリンク
概要
著者
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
東海大学 医学部
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
Takatsuki K
Second Department Of Internal Medicine Kumamoto University School Of Medicine
-
Hata H
Department Of Physics Kyoto University
-
Hata Hiroyuki
Kumamoto Univ. Graduate School Of Medicine Kumamoto Jpn
-
YOSHIDA Minoru
Second Department of Internal Medicine, School of Medicine, Fukuoka University
-
YOSHIDA Minoru
The Second Department of Internal Medicine, Kumamoto University School of Medicine
-
KURIBAYASHI Noriomi
The Second Department of Internal Medicine, Kumamoto University School of Medicine
-
KIMURA Tatsuya
The Second Department of Internal Medicine, Kumamoto University School of Medicine
-
NAGASAKI Akitoshi
Second Department of Internal Medicine, Okinawa-Asia Research Center of Medical Science, Faculty of
-
TAKATSUKI Kiyoshi
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
Takatsuki K
Kumamoto Univ. School Of Medicine Kumamoto Jpn
-
Takatsuki Kiyoshi
Second Department Of Internal Medicine Kumamoto University School Of Medicine
-
Harada Naoko
Department Of Internal Medicine Ii Kumamoto University Schook Of Medicine
-
Takatsuki Kiyoshi
Pharmaceutical Research Laboratory Kirin Brewery
-
Nagasaki Akitoshi
Department Of Endocrinology And Metabolism Ryukyu University School Of Medicine
-
Matsuzaki Hiromitsu
Department Of Internal Medicine Ii Kumamoto University Schook Of Medicine
-
Hata Hiroyuki
Hematology Kumamoto University Graduate School Of Medicine
-
Hata Hiroyuki
Research Laboratory Seitetsu Kagaku Co.
-
Kimura Tatsuya
The Second Department Of Internal Medicine Kumamoto University School Of Medicine
-
Sonoki Takashi
Department Of Hematology And Oncology Wakayama Medical University
-
Sonoki T
Hematology/oncology Wakayama Medical University
-
HATA Hiroyuki
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
MATSUZAKI Hiromitsu
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
SONOKI Takashi
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
KURIBAYASHI Noriomi
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
KIMURA Tatsuya
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
HARADA Naoko
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
Matsuzaki H
Osaka Univ. Osaka Jpn
-
Kuribayashi Noriomi
The Second Department Of Internal Medicine Kumamoto University School Of Medicine
-
Takatsuki Kiyoshi
Second Department Of Internal Medicine Kumamoto University
-
Yoshida Minoru
The Second Department Of Internal Medicine Kumamoto University School Of Medicine
-
Yoshida Minoru
Second Department Of Internal Medicine School Of Medicine Fukuoka University
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma